Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute THC effects on functional brain systems
NL-OMON30656Phase 2Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol, sponsored by University Medical Center Utrecht. Primary endpoint: Blood-oxygen-level dependent signal. Started Mar 2008; status: active, not recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NL-OMON30656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30656.